Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer.

J Am Coll Cardiol 2019 Jun 18

Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer.

Related Questions

Granted adequate target coverage, do you constrain dose to sub-volumes of the heart when treating locally advanced lung cancer?

If so, what sub-volumes and dose constraints do you use?

New answer by Radiation Oncologist at Cedars-Sinai Medical Center (August 14, 2020)

This is a very important question that recent data is beginning to shed light on. It’s difficult to address cardiac sub-structures without first talking about mean heart...

Read more (1 Answer available)

Do you contour and constrain cardiac substructures when treating locally advanced NSCLC with chemoradiation?

If so, which substructures (LAD, left ventricle, etc.)?

New comment by Radiation Oncologist at Minneapolis V.A. Medical Center ( August 22, 2023)

Great responses to date. I include the following constraints for cardiac substructures when planning NSCLC based on additional publications of RTOG 0617 substudies. McKenzie ...

Read more (2 Answers available)

How does the presence of CABG affect your radiotherapy approach for definitive management of locally advanced NSCLC with mediastinal involvement?

E.g. A patient with station 4 and 5 nodal disease and arterial grafts.

New answer by Radiation Oncologist at UCLA | VA Greater Los Angeles Healthcare System (November 13, 2021)

I learned a while ago from @Robert D. Timmerman to not push the intermediate doses around based on hypothesized limits to make ourselves feel better about a plan. We simp...

Read more (2 Answers available)